Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Poirier

Showing results (181-190 of 248) with videos related to

Pageof 25
Sort By:
International Clinical Psychopharmacology|July 17, 2009
Impact of antipsychotic treatments on the motivation to eat: preliminary results in 153 schizophrenic patientsOthman Sentissi, Annie Viala, Marie C Bourdel, et al.
Acta Psychiatrica Scandinavica|March 1, 1992
Natural autoantibodies in schizophreniaA Galinowski, R Barbouche, P Truffinet, et al.
Clinical Chemistry|February 1, 1992
When do gut flora in the newborn produce 3-phenylpropionic acid? Implications for early diagnosis of medium-chain acyl-CoA dehydrogenase deficiencyM J Bennett, A Bhala, S F Poirier, et al.
Pain|March 1, 2005
Altered primary afferent anatomy and reduced thermal sensitivity in mice lacking galectin-1J McGraw, A D Gaudet, L W Oschipok, et al.
The Pharmacogenomics Journal|November 30, 2005
(AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean populationN Ballon, S Leroy, C Roy, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 28, 2000
Evolution of plasma homovanillic acid (HVA) levels during treatment in schizo-affective disorderA Galinowski, C Castelnau, O Spreux-Varoquaux, et al.
L'Encephale|March 1, 1995
[Social adjustment and depression: value of the SAS-SR (Social Adjustment Scale Self-Report)]S Achard, J M Chignon, M F Poirier-Littré, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 23, 2003
5HTTLPR polymorphism in schizophrenic patients: further support for association with violent suicide attemptsF J Bayle, S Leroy, D Gourion, et al.
Psychopharmacology|March 1, 1996
In vivo characteristics of dopamine D2 receptor occupancy by amisulpride in schizophreniaJ L Martinot, M L Paillère-Martinot, M F Poirier, et al.
Acta Psychiatrica Scandinavica|February 1, 1990
Diagnostic and therapeutic value of testing stimulation of thyroid-stimulating hormone by thyrotropin-releasing hormone in 100 depressed patientsJ M Vanelle, M F Poirier, C Benkelfat, et al.
Pageof 25

Showing results (181-190 of 248) with videos related to

Sort By:
Pageof 25
International Clinical Psychopharmacology|July 17, 2009
Impact of antipsychotic treatments on the motivation to eat: preliminary results in 153 schizophrenic patientsOthman Sentissi, Annie Viala, Marie C Bourdel, et al.
Acta Psychiatrica Scandinavica|March 1, 1992
Natural autoantibodies in schizophreniaA Galinowski, R Barbouche, P Truffinet, et al.
Clinical Chemistry|February 1, 1992
When do gut flora in the newborn produce 3-phenylpropionic acid? Implications for early diagnosis of medium-chain acyl-CoA dehydrogenase deficiencyM J Bennett, A Bhala, S F Poirier, et al.
Pain|March 1, 2005
Altered primary afferent anatomy and reduced thermal sensitivity in mice lacking galectin-1J McGraw, A D Gaudet, L W Oschipok, et al.
The Pharmacogenomics Journal|November 30, 2005
(AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean populationN Ballon, S Leroy, C Roy, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 28, 2000
Evolution of plasma homovanillic acid (HVA) levels during treatment in schizo-affective disorderA Galinowski, C Castelnau, O Spreux-Varoquaux, et al.
L'Encephale|March 1, 1995
[Social adjustment and depression: value of the SAS-SR (Social Adjustment Scale Self-Report)]S Achard, J M Chignon, M F Poirier-Littré, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 23, 2003
5HTTLPR polymorphism in schizophrenic patients: further support for association with violent suicide attemptsF J Bayle, S Leroy, D Gourion, et al.
Psychopharmacology|March 1, 1996
In vivo characteristics of dopamine D2 receptor occupancy by amisulpride in schizophreniaJ L Martinot, M L Paillère-Martinot, M F Poirier, et al.
Acta Psychiatrica Scandinavica|February 1, 1990
Diagnostic and therapeutic value of testing stimulation of thyroid-stimulating hormone by thyrotropin-releasing hormone in 100 depressed patientsJ M Vanelle, M F Poirier, C Benkelfat, et al.
Pageof 25